Developing Story
Silimed vs. Polytech – Breast Implant Patent Dispute (Munich UPC)
Silimed, a Brazilian breast implant manufacturer, won a preliminary injunction at the UPC Munich Local Division against German rival Polytech after successfully completing an entitlement action to transfer patent ownership away from Polytech. The case is a rare example of using a UPC entitlement action offensively and then immediately enforcing the newly acquired patent against its former owner.
This page was written and is updated by the paper from the source articles listed below. Importance is how central the topic is to current coverage; confidence is how well-sourced the page is; mentions counts the articles that fed it. How the wiki works →
## Overview
Brazilian medical device manufacturer Silimed has obtained a preliminary injunction against German competitor Polytech at the Munich Local Division of the UPC, following a successful entitlement action that transferred ownership of a key breast implant manufacturing patent from Polytech to Silimed. This case is notable for combining an entitlement/ownership dispute with subsequent infringement enforcement against the former patent owner.
## Key Facts
- **Patent at issue**: Covers manufacture of breast implants (specific EP number not yet public).
- **Entitlement action**: Silimed successfully challenged Polytech's ownership of the patent, resulting in transfer of rights to Silimed.
- **PI granted**: Munich Local Division issued preliminary injunction against Polytech following the ownership transfer.
- **Unusual posture**: Polytech is both the former patent owner and the now-accused infringer—a rare litigation configuration.
## Strategic Significance
### For IP Litigators
- Demonstrates that UPC entitlement actions (disputes over who rightfully owns a patent) can be a viable offensive tool, not just a defensive one.
- Munich Local Division shown willing to grant PI immediately following entitlement resolution—courts not requiring extended post-transfer delay.
- Medical device sector increasingly active at UPC alongside pharma and consumer tech.
### For Companies
- Brazilian manufacturers can use European IP infrastructure offensively against European incumbents.
- Entitlement actions present underutilized strategic leverage in competitive IP disputes.
- Companies holding patents should audit chain-of-title carefully; ownership vulnerabilities can be exploited by competitors.
## Parties
| Party | Role |
|---|---|
| Silimed | Brazilian manufacturer, new patent owner/Claimant |
| Polytech | German manufacturer, former owner/Defendant |
| UPC Munich Local Division | Court |
## Watch Points
- Whether Polytech successfully challenges the PI or the underlying entitlement ruling on appeal.
- Scope of the injunction and whether it impacts Polytech's broader product line.
- Whether Silimed pursues damages following PI.
- Precedential value of the entitlement-to-PI pathway at UPC.